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In mammals, the inducible cytokine interleukin 10 is a feedback negative regulator of inﬂammation. To
determine the extent to which this function is conserved in birds, recombinant chicken IL-10 was
expressed as a secreted human Ig Fc fusion protein (chIL-10-Fc) and used to immunise mice. Five
monoclonal antibodies (mAb) which speciﬁcally recognise chicken IL-10 were generated and charac-
terised. Two capture ELISA assays were developed which detected native chIL-10 secreted from chicken
bone marrow-derived macrophages (chBMMs) stimulated with lipopolysaccharide (LPS). Three of the
mAbs detected intracellular IL-10. This was detected in only a subset of the same LPS-stimulated
chBMMs. The ELISA assay also detected massive increases in circulating IL-10 in chickens challenged
with the coccidial parasite, Eimeria tenella. The same mAbs neutralised the bioactivity of recombinant
chIL-10. The role of IL-10 in feedback control was tested in vitro. The neutralising antibodies prevented IL-
10-induced inhibition of IFN-g synthesis by mitogen-activated lymphocytes and increased nitric oxide
production in LPS-stimulated chBMMs. The results conﬁrm that IL-10 is an inducible feedback regulator
of immune response in chickens, and could be the target for improved vaccine efﬁcacy or breeding
strategies.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Interleukin-10 (IL-10) is an anti-inﬂammatory cytokine that
controls the nature and extent of inﬂammatory responses during
infection with viruses, bacteria, fungi, protozoa and helminths
(Couper et al., 2008; Moore et al., 2001) and has a particular
central role in intestinal immunity and homeostasis (Manzanillo
et al., 2015). IL-10 was ﬁrst described as an inhibitor of cytokine
synthesis in mice, a product of the TH2 subset of T cells that
inhibited synthesis of proinﬂammatory cytokines by TH1 cells
(Fiorentino et al., 1989). IL-10 is now recognised as a multifunc-
tional cytokine produced by many immune cell types including
macrophages, monocytes, dendritic cells (DCs), TH1, TH2, TH17
and regulatory T cell subsets and B cells and a feedback regulator
of diverse immune responses to infections (Reviewed in Couper
et al., 2008; Moore et al., 2001; Saraiva and O'Garra, 2010).Hume).
r Ltd. This is an open access articleAccordingly, vaccine efﬁcacy in mammals has been associated
with genetic variation in IL-10 production, and anti-IL-10 treat-
ment has been shown to increase the nature, magnitude and ef-
ﬁcacy of vaccine responses against a diversity of pathogens (Chen
et al., 2014; Darrah et al., 2010; Pitt et al., 2012; Roberts et al.,
2005; Stober et al., 2005).
Infectious diseases are a major threat to intensive poultry pro-
duction. There is less evidence of the function of IL-10 in birds. The
cDNA of chicken IL-10 (chIL-10) was isolated from cecal tonsils of
Eimeria tenella-infected chickens (Rothwell et al., 2004) and the
expressed protein product inhibited IFN-g synthesis by mitogen-
activated lymphocytes (Rothwell et al., 2004). Inducible expres-
sion of IL-10 mRNA has been described in viral, bacterial and
parasitic infections of birds (Barjesteh et al., 2013; Humphrey et al.,
2014; Parvizi et al., 2015). However, the lack of reagents has pre-
vented analysis of the production and function of IL-10 protein. In
the current study we describe the generation of monoclonal anti-
bodies to chIL-10 and their applications in western blot, capture
ELISA and neutralising assays. The results indicate that IL-10 has
similar functions in birds as in mammals. As predicted from theunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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infection of chickens produced a massive increase in circulating IL-
10, providing a biomarker for disease status. Accordingly, we sug-
gest that manipulation of IL-10, either through genetic or thera-
peutic intervention, could have application in reducing disease
burden in chickens.
2. Materials and methods
2.1. Expression and puriﬁcation of recombinant chIL-10-Fc and
recombinant chIL-10-V5H6 protein
ChIL-10 cDNA was sub-cloned into the vector, pKW06 (John
Young, unpublished) to express the protein in mammalian cells
with a C-terminal human IgG1 Fc tag. For screening purposes, to
eliminate anti-human Ig antibodies, a V5His tagged chIL-10 was
produced in the vector pKW08 (John Young and Tuanjun Hu, un-
published). ChIL-10 cDNAs (Rothwell et al., 2004) were expressed
with the native signal peptide allowing secretion of the fusion
proteins. Both constructs were expressed in COS-7 cells following
transfection using the DEAE-dextran method (Rothwell et al.,
2004). Recombinant chIL-10-Fc protein was puriﬁed using a
HiTrap Protein G afﬁnity column and the chIL-10-V5H6 protein
with a HisTrap excel column (GE Healthcare Life Sciences).
2.2. Monoclonal antibody production, isotyping, puriﬁcation, and
labelling
Immunisation with chIL-10-Fc and fusion to generate hybrid-
omas was carried out by Dundee Cell Products (DCP, Dundee, UK).
Following fusion, hybridoma cultures were tested with recombi-
nant chIL-10-V5H6 by dot-blot. Supernatants from these cultures
were screened by ELISA with chIL-10-V5H6 and chIL-10-Fc and
Western-Blot. Positive cultures were selected for further cloning.
The antibody isotype was determined using the IsoStrip Mouse
Monoclonal Antibody Isotyping Kit (Roche). Monoclonal hybrid-
omas were cultured in D-MEM with 10% Ig-depleted FBS. Mono-
clonal antibodies were puriﬁed using HiTrap Protein G afﬁnity
columns and dialysed against PBS using 30 kDa molecular weight
cut-off (MWCO) Slide-A-Lyser cassettes (Pierce, ThermoFisher Sci-
entiﬁc). The concentrations of mAbs were determined by absor-
bance at 280 nmwith a Nanodrop and then aliquots of the puriﬁed
antibodies were biotinylated using Sulfo-NHS-LC-LC-biotin
(Thermo Scientiﬁc). All procedures were performed according to
the manufacturer's instructions.
2.3. Western blot
Recombinant chIL-10-V5H6 was treated with SDS-PAGE
reducing buffer, denatured for 5 min at 100 C and loaded onto a
4e15% pre-cast Mini-PROTEAN TGX Gels (Bio-Rad) and transferred
onto a nitrocellulose membrane (Immunobilon-P, Millipore) using
a Trans-Blot Semi-Dry Electrophoretic Transfer Cell (Bio-Rad). After
blocking with 0.5% skimmed milk power/PBS solution, the mem-
brane was stained with 1.0 mg/ml of each mAb, followed by incu-
bation with goat anti-mouse IgG1-horseradish peroxidase
(Southern Biotec) diluted in 0.5% skimmed milk powder/PBS.
Detection was carried out using enhanced chemiluminescence
(ECL) (GE Healthcare Life Sciences), according to themanufacturer's
instructions.
2.4. Detection of chicken IL-10 by indirect ELISA and development
of capture ELISA assays
Indirect ELISA was performed as described previously (Rothwellet al., 2001). Brieﬂy, assay plates (Nunc Immuno MaxiSorp, Thermo
Electron LED) were coated with recombinant chIL-10 or control
protein in Carbonate/Bicarbonate buffer and incubated overnight at
4 C. Plates werewashed in PBS containing 0.05% Tween-20 (PBS-T)
and blocked with 0.5% casein/PBS at room temperature (RT) for 1 h.
Puriﬁed mAbwas added to the plate at a 1.0 mg/ml and incubated at
RT for 1 h. After three washes with PBS-T, plates were incubated
with goat anti-mouse IgG-HRP at RT for 1 h. After a further three
washes, plates were visualised by TMB substrate (Thermo Scienti-
ﬁc) and reaction was stopped by 2 N H2SO4. Plates were read at
450 nm in a SpectraMax 250microplate spectrophotometer system
(Molecular Devices, Sunnyvale, CA, USA). Two capture ELISA assays
was developed using ROS-AV162 or 164 as capture antibody and
biotinylated ROS-AV163 as detecting antibody. Brieﬂy, assay plates
were coated with capture antibody ROS-AV162 or ROS-AV164 at
4 mg/ml overnight at 4 C. Plates werewashed and blocked as in the
indirect ELISA. Plates were incubated with recombinant IL-10
standards, or test samples at RT for 1 h, then washed and incu-
bated with biotinylated detecting antibody ROS-AV163 at 1 mg/ml
at RT for 1 h. After three washes, plates were incubated with
streptavidineHRP (1:10,000, Pierce) for a further hour at RT before
adding substrate 1-step TMB (Thermo Scientiﬁc) and then sulfuric
acid stop solution. Absorbance was read at 450 nm.2.5. Detection of IL-10 production by bone marrow derived
macrophages (BMMs)
Chicken BMMs were cultured from bone marrow cells from
ED20 Novogen embryos in the presence of recombinant chicken
CSF-1 as previously described (Garceau et al., 2010). On day 7 of
culture, cells were stimulated with 0.5 mg/ml of LPS (Eimeria coli
serotype 055:B5, Sigma) to induce IL-10 expression. Cell culture
supernatant from BMMs cells was collected at various times and IL-
10 was detected using the capture ELISA. To detect intracellular IL-
10 protein, the BMM cells were stimulated with 0.5 mg/ml of LPS for
2 h before Brefeldin A (10 mg/ml, Sigma-Aldrich) was added to the
culture to block secretion. Cells were resuspended in Fixation/
Permeabilization solution (BD Bioscience) for 20 min at 4 C,
washed twice with 1 BD Perm/Wash™ buffer, and incubated with
ROS-AV160-164 at 1.0 mg/ml in 1 BD Perm/Wash™ for 30 min at
4 C. Cells were washed as before and resuspended in 0.4 mg/ml
Alexa Fluor 647 goat anti-mouse IgG1 (Invitrogen/A-21240). Cells
were washed then three times before analysing on FACScalibur (BD
Bioscience).2.6. Infection of chicken with E. tenella and measurement of
circulating IL-10
Commercial broiler birds (Cobb 500) were reared under SPF
conditions from day of hatch and screened by faecal ﬂotation to
conﬁrm the absence of prior Eimeria infection. Birds were inocu-
latedwith a low (4000) or high (35,000) dose of E. tenellaHoughton
strain sporulated oocysts, or mock dosed using sterile phosphate
buffered saline, at 4 weeks post hatch (n ¼ 6). Serum was taken
following brachial vein blood collection 2 days prior to infection
(2 dpi), 5 days post infection (dpi) and 8 dpi. This study was
carried out in strict accordance with the Animals (Scientiﬁc Pro-
cedures) Act 1986, an Act of Parliament of the United Kingdom,
following approval by the Royal Veterinary College Ethical Review
Committee and the United Kingdom Government Home Ofﬁce
under the project licence 70/7781. The levels of IL-10 in the sera
were measured by capture ELISA using ROS-AV164 as capturing
antibody and biotinylated ROS-AV163 as detecting antibody.
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ChIL-10 bioassay was performed as described previously
(Rothwell et al., 2004). Brieﬂy, splenocytes were isolated from 8
week old birds over Histopaque and resuspended at 5  106 cell/ml
in DMEM containing 2 mg/ml BSA, 1% L-glutamine, 1 U/ml peni-
cillin, and 1 mg/ml streptomycin. Cells were added to round-bottom
96-well plates (100 ml/well) containing serial 5-fold dilutions of
rchIL-10 or negative controls (including control protein tagged with
HuIgG1 Fc, control protein tagged withV5H6, pCIneo supernatant),
in a ﬁnal volume of 200 ml in the presence of 0.5 mg/ml of ConA
(Sigma-Aldrich) or no ConA. Plates were incubated at 41 C for 72 h
for analysis of IFN-g content in the supernatant by capture ELISA
(IFN-gamma chicken antibody pair, Novex, Life technologies, UK) as
per manufacturer's instructions. For neutralisation assay, rchIL-10
was pre-incubated with 2-fold diluted mAbs or a control mAb
with a starting concentration of 4 mg/ml at 37 C for 2 h before
adding lymphocytes and ConA.
2.8. Nitric oxide assay
Chicken BMMswere cultured on 96 well plates as above. On day
7 of culture, cells were stimulated with 0.5 mg/ml of LPS (E. coli
serotype 055:B5, Sigma) with or without mAbs ROS-AV160 to 164.
Supernatant was collected at 24 h after treatment to measure ni-
trite, a stable metabolite of nitric oxide, by Griess assay. Brieﬂy,
100 ml of culture supernatant from each well was transferred to a
new ﬂat-bottom 96-well plate. Griess reagent was prepared by
mixing equal volumes of components A (0.2% a-napthyl ethylene
diamine dihydrochloride in dH2O) and B (2% sulfanilimide in 5%
phosphoric acid in dH2O). Equal amount of Griess reagent was
added to each wells. After 10 min incubation at room temperature,
the plates were read at 570 nm in a SpectraMax 250 microplate
spectrophotometer system (Molecular Devices, Sunnyvale, CA,
USA). Sodium nitrite (Promega) was used as a standard to deter-
mine nitrite concentrations.
3. Results and discussion
3.1. Production of mouse anti-chicken IL-10 monoclonal antibodies
The predictedmolecular weight of the expressed chIL-10-Fc and
chIL-10-V5H6 proteins are 46.53 kDa and 20.97 kDa. Following
expression and puriﬁcation as described in the Methods, the purity
and molecular weight were conﬁrmed by SDS-PAGE (Fig. 1A). The
puriﬁed chIL-10-Fc fusion protein was used to immunise mice for
generation of mAbs. Seventeen initial hybridoma supernatants
reactive with chIL-10-Fc were tested for speciﬁc binding to chIL-10Fig. 1. (A) SDS-PAGE showing the purity and molecular weight of chIL-10-V5H6 (lane 1) an
4H5, 8E11 and 8E3 recognised chIL-10-V5H6 by WB. These ﬁve clones were selected to proby WB and ELISA (Figs. 1B and 2). Eight supernatants recognised
chIL-10 but not control-Ig by ELISA and ﬁve of these also bound
chIL-10-V5H6 byWB. The corresponding lines were cloned and ﬁve
IgG1 monoclonal antibodies (ROS-AV160 (4H5), ROS-AV161 (3D8),
ROS-AV162 (8E11), ROS-AV163 (8E3), ROS-AV164 (1E8)) were
produced.
3.2. Characterisation of mAbs by indirect ELISA and western blot
(WB)
All ﬁve monoclonal antibodies reacted speciﬁcally with re-
combinant chIL-10, by ELISA (Fig. 3) and bound both the 47 kDa of
chIL-10-Fc and 21 kDa of chIL-10-V5H6 (Supplemental material
Fig. S1). Based upon epitope blocking experiments (data not
shown), ROS-AV160 and ROS-AV161 recognise the same or closely-
related epitopes on IL-10, whereas ROS-AV162, ROS-AV163 and
ROS-AV164 recognised different epitopes. Accordingly, these anti-
bodies in combination were considered appropriate to establish a
capture ELISA.
3.3. Detection of native chIL-10 by capture ELISA and intracellular
staining
Two capture ELISA assays for chIL-10 were developed using
different combinations of mAbs. Both assays give the same sensi-
tivity so only data from one assay (capturing with ROS-AV164 and
detecting with biotinylated ROS-AV163) was carried forward. The
sensitivity range of this assay was between 8 pg/ml to 1 ng/ml
(Fig. 4A). Many cells of the innate immune system, including
macrophages, dendritic cells, mast cells, NK cells, eosinophils and
neutrophils express IL-10 (Saraiva and O'Garra, 2010). In mammals
at least, macrophages can express IL-10 in vitro following activation
of speciﬁc PRRs with LPS (Chang et al., 2007) or other TLR agonists
(Boonstra et al., 2006). In the chicken, activation of TLR3 and TLR21
through poly I:C (double-stranded RNA) or CpG-ODN (a CpG-motif
containing oligodeoxydinucleotide) respectively induced IL-10
mRNA in monocytes (He et al., 2012). In splenocytes, IL-10 mRNA
was induced transiently in response to various bacterial lip-
opolysacharides (Barjesteh et al., 2013).
The ELISA was used to detect secretion of chIL-10 by LPS-
stimulated BMMs (Fig. 4B). ChIL-10 in the supernatant was
rapidly induced from 2 h post stimulation with LPS, reached a
maximum after 4 h and went down gradually. In stimulated human
(Xue et al., 2015) andmousemacrophages (Ravasi et al., 2002), only
a subset of cells express each individual inducible cytokine. Intra-
cellular cytokine detection by ﬂow cytometry allows studying
cytokine production at single cell level together with other cyto-
kines or cell surface markers. The anti-chIL-10 antibodies wered chIL-10-Fc (lane 2). (B) Screening of hybridoma supernatant by WB. Clone 1E8, 3D8,
duce monoclonal antibodies.
Fig. 2. Screening of hybridoma supernatant by ELISA. Values represent the mean of duplicate wells. Clone 1E8, 3D8, 3G2, 4D9, 4H5, 8E11, 8D8 and 8E3 recognised chIL-10 but not
control-Fc.
Fig. 3. Speciﬁcity of mouse anti-chIL-10 mAb as demonstrated by indirect ELISA against rchIL-10-Fc, control-Fc, chIL-10-V5H6 and control-V5H6. All ﬁve monoclonal antibodies
speciﬁcally recognised recombinant chIL-10 not Fc or V5H6 tagged control protein. Values represent the mean of duplicate wells.
Fig. 4. (A) Capture ELISA with ROS-AV164 as the capture antibody at 4 mg/ml and biotinylated ROS-AV163 at 1 mg/ml as detecting antibody. Recombinant chIL-10-Fc was used as
standard. PBS was used as negative control. Values represent the mean of duplicate wells. (B) Native chIL-10 in LPS-stimulated BMMs culture in a time course was detected by the
above capture ELISA. Values represent the mean of three independent experiments. Error bars represent standard error of the mean.
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LPS for 2 h and BFA was used to block the secretion of chIL-10
(Fig. 5). Both ROS-AV162 and 163 detected intracellular chIL-10,
but surprisingly only around 10% of the LPS-stimulated chBMMS
were positive. This result suggest that the secreted IL-10 may be
produced by only a subset of the stimulated macrophages, and
might therefore act in a paracrine manner on neighbouring cells.3.4. Detection of circulating IL-10 after E. tenella infection
IL-10 is a key immunoregulator during infectionwith pathogens
including intracellular protozoa (Gazzinelli et al., 1996; Wilson
et al., 2005). As in mammalian species, chicken IL-10 has
emerged to be a crucial player in the Th bias during infection with
Eimeria spp., preventing the development of strong, IFN-g-driven
responses, which have been shown to be crucial for control of
Fig. 5. Detection of intracellular chIL-10 in LPS-stimulated chBMMs. After 7-days culture, ChBMMs were stimulated with LPS for 2 h or non-stimulated before adding Brefeldin A for
further 4 h. Cells were ﬁxed, permeabilised and stained as described in materials and methods. Cells debris were gated out. SSC: side scatter.
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the serum of healthy uninfected birds. As expected from previous
detection of the IL-10 mRNA in infected birds (Rothwell et al.,
2004), the level of circulating IL-10 was substantially increased
around 5 days following either low or high dose challenge (Fig. 6).Fig. 6. Circulating IL-10 was detected in the serum from chicken infected with
E. tenella at 5 dpi. Six birds were used for each group. Student's t-test was used to
determine signiﬁcance (P < 0.05, indicated by an asterisk) of IL-10 production in
infected birds, when compared to the relevant control.These observations indicate that circulating IL-10 could provide a
marker for infection, and that Eimeria infections could produce
systemic immunosuppression.Fig. 7. Effect of rchIL-10 on the ability of splenocytes to express IFN-g after mitogen
stimulation. Splenocytes were unstimulated or ConA stimulated with different con-
centrations of rchIL-10 and controls. All the control proteins showed no effect on ConA
stimulation, only results from Ig-tagged control protein was shown in the graph. IFN-g
expression at 72 h was measured by capture ELISA. The doubling dilutions started from
a 1/20 dilution for neoIL-10 and 128 ng/ml for rchIL-10-Fc or chIL-10-V5H6.
Fig. 8. Neutralising effect of mAbs to chIL-10. ChIL-10 was incubated with mAbs for 2 h before IL-10 bioassay as in Fig. 7. Assays were carried out in triplicate, and representative
data from three independent experiments is shown.
Fig. 9. Up-regulation of NO production by mAbs to IL-10. ChBMMs produced NO in
response to LPS. Neutralising mAbs to chIL-10 (ROS-AV162, 163 and 164) up-regulated
the production of NO by LPS-stimulated chBMMs. Assays were carried out in triplicate,
and representative data from three independent experiments is shown.
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activation
Mammalian IL-10 strongly inhibited proliferation of CD4þ Tcells
and production of cytokines including IFN-g, IL-2, IL-4 and TNF-a
(Couper et al., 2008; Joss et al., 2000; Moore et al., 2001). As in
mammals, chIL-10 inhibits the expression of IFN-g by mitogen-
activated splenocytes (Rothwell et al., 2004). Each of the forms of
IL-10 produced for this study inhibited IFN-g expression by sple-
nocytes after mitogen stimulation (ConA). A 1/80 dilution of neoIL-
10 or 32 ng/ml of chIL-10-V5H6 or 8 ng/ml of chIL10-Fc completely
inhibited IFN-g expression (Fig. 7). Preincubation with ROS-AV160
and 161 did not neutralise rchIL-10 even at a concentration of
4 mg/ml. However ROS-AV162, 163 and 164 completely neutralised
the inhibition effect by rchIL10 at high concentrations, and this
effect titrated out with increasing dilution of mAbs (Fig. 8). These
neutralising antibodies provide useful tools to study the regulatory
role of IL-10 in chicken immune system as well as the molecular
interaction with its receptor.
To test the potential paracrine role of IL-10, implied by the
expression in subsets of macrophages above, we tested the impact
of adding the neutralising antibodies to stimulated macrophages.
Nitric oxide production in mice contributes to macrophage cyto-
toxicity towards pathogens including parasites, fungi and bacteria.
Mouse macrophages produce NO after activation with LPS. This
activity is not shared by the macrophages of large animals,
including humans and pigs (Kapetanovic et al., 2012; Schroder
et al., 2012). IL-10 inhibits NO production of activated mouse
macrophages and compromises cytotoxic functions (Gazzinelli
et al., 1992; Oswald et al., 1992; Romani et al., 1994). Neutralisa-
tion of endogenous IL-10 by anti-IL-10 antibodies up-regulated
nitric oxide production in murine macrophages in vitro and pro-
tected susceptible mice from challenge with Candida albicans
(Romani et al., 1994). Anti-IL-10 treatment in vivo results in asubstantial and signiﬁcant increase in LPS-induced serumNO levels
in amousemodel (ter Steege et al., 1998). Like mousemacrophages,
chicken macrophages produced abundant NO following activation
with LPS or cytokines (Lillehoj and Li, 2004; Sung et al., 1991;
Weining et al., 1996). As shown in Fig. 9, this activity is conve-
niently assayed in chBMMs. Incubation with the neutralising mAbs
ROS-AV162, 163 and 164 signiﬁcantly up-regulated the NO con-
centrations by LPS-stimulated BMMs in a dose-dependent manner,
where the non-neutralising antibodies had no effect.
4. Conclusion
We have produced ﬁvemousemAbs to chicken IL-10 using chIL-
10-Fc as immunogen. All ﬁve monoclonal antibodies recognised
speciﬁcally chIL-10 via ELISA and WB. Two capture ELISA assays
were developed to quantify native IL-10. Three mAbs (ROS-AV162,
163 and 164) neutralised the bioactivities of chIL-10 on ConA
stimulated splenocytes and upregulated the nitric oxide production
by LPS-stimulated chBMMs. These antibodies are new tools to
investigate the important role of IL-10 in the chicken immunity and
diseases. The data indicate that IL-10 is immunosuppressive in
chickens as it is in mammals, and suggest that intervention in IL-10
production could be used to manipulate chicken immune
responses.
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